Page 196 - Genentech News Today

With a new drug and returning strength, East Wareham singer Pidgie Panzarino hits the tour stage with a disease that has killed many.

New training and EHR support tool could help busy pediatric clinicians identify high-risk infants and implement latest feeding guidelines.

Etrasimod was effective and well tolerated as an induction and maintenance therapy in patients with moderately to severely active ulcerative colitis. Etrasimod is a treatment option with a unique combination of attributes that might address the persistent unmet needs of patients with ulcerative colitis.

Operator: Greetings. Welcome to the Immunocore 2022 Financial Results and Business Update Call. Please note, this conference is being recorded.

The study findings add new insights, but also raise new questions, about the best treatment approach for Philadelphia chromosome-positive acute lymphoblastic leukemia.

Investegate announcements from Oxford BioDynamics, Publication of FY22 Annual Report

/PRNewswire/ -- Today Grey Group announces the latest addition to its global leadership team: Gabriel Schmitt joins as Global Chief Creative Officer. He will...

Industry news related to area economic development, corporate relocation, company expansion and site selection throughout Oregon.

A patient faced paying almost $5,000 for infusions after her insurer denied coverage — even though it covered the drug before.

Nine analysts raise stock price targets for Apellis Pharmaceuticals after it wins the FDA's first approval for a geographic atrophy therapy.